7 completed, 2 recruiting, 1 terminated, 1 unknown. 11 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 11 | Completed 7, Recruiting 2, Terminated 1, Unknown 1 |
| Phase 2 | 2 | Recruiting 2 |
Follow Tremor: new trials by email Literature Review of Tremor trials Research Report on Tremor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bilateral Essential Tremor Treatment With Gamma Knife Gamma Knife VIM thalamotomy - Essential Tremor | Phase 2 / Phase 3 | Recruiting | Université de Sherbrooke | 50 | 2021-06-08 | 2021-11-17 |
| CIRTEN-Simultaneous Pancreas-Kidney Transplant Recipients Envarsus XR - Kidney Pancreas Transplantation | Phase 2 / Phase 3 | Recruiting | University of Wisconsin, Madison | 20 | 2019-02-27 | 2026-10-29 |
| Intravenous Dexmedetomidine for Treatment of Shivering During Cesarean Section Under Neuraxial Anesthesia Dexmedetomidine, Normal saline - Tremor | Phase 3 | Completed | St. Justine's Hospital | 80 | 2015-04-01 | 2018-04-19 |
| Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO) Prograf, LCP-Tacro - Renal Failure, Tremors | Phase 3 | Completed | Veloxis Pharmaceuticals | 44 | 2011-12-01 | 2015-10-01 |
| Two Separate But Identical Studies Evaluating the Safety and Efficacy of ALTROPANE® in the Use of SPECT Imaging for Upper Extremity Tremor 123 I - ALTROPANE® - Parkinsonian Syndromes | Phase 3 | Unknown | Alseres Pharmaceuticals, Inc | 240 | 2010-07-01 | 2010-02-03 |
| The Efficacy of Botulinum Toxin in Disabling Multiple Sclerosis (MS) Tremor Botulinum Toxin Type A - Multiple Sclerosis, Tremor | Phase 3 | Completed | Melbourne Health | 30 | 2008-10-01 | 2015-05-12 |
| Gabapentin for the Treatment of Neuroleptic-Induced Tremor Gabapentin - Neuroleptic-Induced Tremor | Phase 3 | Terminated | Minneapolis Veterans Affairs Medical Center | 40 | 2004-03-01 | 2007-09-24 |
| Phase II Subthalamic Nucleus (STN) vs. Globus Pallidus (GPi) Trial Bilateral Deep Brain Stimulation - Parkinson's Disease | Phase 3 | Completed | US Department of Veterans Affairs | 299 | 2002-04-01 | 2014-07-14 |
| Phase I Deep Brain Stimulation (DBS) vs. Best Medical Therapy (BMT) Trial Bilateral Deep Brain Stimulation, best medical therapy - Parkinson's Disease | Phase 3 | Completed | US Department of Veterans Affairs | 255 | 2002-04-01 | 2014-05-09 |
| A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Treating Tremor of Unknown Cause. topiramate - Essential Tremor | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 223 | 2001-10-01 | 2011-06-10 |
| Timing of Levodopa Treatment in Parkinson's Disease levodopa - Parkinson's Disease | Phase 3 | Completed | National Institute of Neurological Disorders and Stroke (NINDS) | 1998-01-01 | 2005-06-24 |
Parkinson Disease (4) · Dyskinesias (3) · Essential Tremor (3) · Central Nervous System Diseases (1) · Disease (1) · Movement Disorders (1) · Multiple Sclerosis (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Parkinsonian Disorders (1) · Renal Insufficiency (1)
Pathological Conditions, Signs and Symptoms (11) · Signs and Symptoms (11) · Nervous System Diseases (10) · Neurologic Manifestations (10) · Dyskinesias (8) · Central Nervous System Diseases (5) · Movement Disorders (5) · Basal Ganglia Diseases (4) · Brain Diseases (4) · Neurodegenerative Diseases (4) · Synucleinopathies (4) · Parkinsonian Disorders (3) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Demyelinating Autoimmune Diseases, CNS (1)
Tacrolimus (2) · Botulinum Toxins, Type A (1) · Dexmedetomidine (1) · Gabapentin (1) · Levodopa (1) · Saline Solution (1) · Topiramate (1)
US Department of Veterans Affairs (2) · Alseres Pharmaceuticals, Inc (1) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1) · Melbourne Health (1) · Minneapolis Veterans Affairs Medical Center (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1) · St. Justine's Hospital (1) · University of Wisconsin, Madison (1) · Université de Sherbrooke (1) · Veloxis Pharmaceuticals (1)
United States (7) · Canada (2) · Australia (1)
Kenneth Follett (2) · Adityanjee Adityanjee, MD (1) · Alan Glicklich, MD (1) · Andrew Evans, MD (1) · Charles E Dean, MD (1) · Christina Lamontagne, MD (1) · Edith Villeneuve (1) · Frances M. Weaver, PhD MA BA (1) · Jon S Odorico, MD (1) · Sandra Lesage (1) · Stanley Fahn (1)
PMID 19126811, PMID 20519680, PMID 23667214, PMID 25185211, PMID 41626017, PMID 16216957, PMID 16381181, PMID 17052655, PMID 19454631, PMID 20830819, PMID 20937936, PMID 22722632, PMID 30945105